510(k) K190189

MDT2 BLE Self-Monitoring Blood Glucose System by Eps Bio Technology Corp. — Product Code NBW

K190189 is an FDA 510(k) premarket notification submitted by Eps Bio Technology Corp. for the device "MDT2 BLE Self-Monitoring Blood Glucose System". The FDA issued a decision of Substantially Equivalent on November 1, 2019. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345. Eps Bio Technology Corp. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 1, 2019
Date Received
February 1, 2019
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
System, Test, Blood Glucose, Over The Counter
Device Class
Class II
Regulation Number
862.1345
Review Panel
CH
Submission Type